Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Research & Development (2009 - 2025)

Evotec SE's (EVO) quarterly Research & Development came in at -$11.4 million in Q4 2025, down 10.04% year-over-year from -$12.7 million in Q4 2024, and down 12.31% quarter-over-quarter from -$10.2 million in Q3 2025.

Analysis

Evotec SE (EVO) Research & Development (2009 - 2025) Analysis & Trends

Evotec SE has disclosed Research & Development across 9 years of filings, most recently posting -$11.4 million for Q4 2025.

  • In Q4 2025, Research & Development fell 10.04% year-over-year to -$11.4 million; the TTM figure through Dec 2025 stood at -$42.2 million (up 23.48% YoY), while the FY2025 annual figure was -$42.4 million, up 23.01% from the prior year.
  • Research & Development came in at -$11.4 million for Q4 2025 at Evotec SE, down from -$10.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $21.3 million in Q3 2021 to a low of -$143.8 million in Q4 2021.
  • Average Research & Development over 5 years is -$25.6 million, with a median of -$15.9 million recorded in 2024.
  • Year-over-year, Research & Development decreased 12.4% in 2022 and soared 83.89% in 2023.
  • Over 5 years, Research & Development stood at -$143.8 million in 2021, then gained by 6.35% to -$134.6 million in 2022, then soared by 83.89% to -$21.7 million in 2023, then jumped by 52.08% to -$10.4 million in 2024, then retreated by 10.04% to -$11.4 million in 2025.
  • Per Business Quant data, the three most recent Research & Development figures were -$11.4 million in Q4 2025, -$10.2 million in Q3 2025, and -$9.3 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn -
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn -
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn -
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn -
6 Evotec SE 642.83 Mn 216.96 Mn - -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn 46.21 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 2.35 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 1.15 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn - 1.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -11.44 Mn
Sep 30, 2025 -10.19 Mn
Jun 30, 2025 -9.29 Mn
Mar 31, 2025 -11.32 Mn
Dec 31, 2024 -10.40 Mn
Sep 30, 2024 -13.04 Mn
Jun 30, 2024 -14.11 Mn
Mar 31, 2024 -17.64 Mn
Dec 31, 2023 -21.69 Mn
Jun 30, 2023 -20.13 Mn
Dec 31, 2022 -134.63 Mn
Sep 30, 2022 18.63 Mn
Jun 30, 2022 -19.98 Mn
Mar 31, 2022 -20.33 Mn
Dec 31, 2021 -143.77 Mn
Sep 30, 2021 21.27 Mn
Jun 30, 2021 -20.44 Mn
Mar 31, 2021 -22.27 Mn
Dec 31, 2020 -131.18 Mn
Sep 30, 2020 19.02 Mn